News by Subject Policy & Ethics

Confusion and ambiguity in how US patients and researchers perceive genetic privacy is uncovered by a study published Oct. 31, 2018 in the open-access journal PLOS ONE by Ellen W. Clayton from Vanderbilt University, USA, and colleagues.

New study finds that between 1999 and 2014, only 25 new antibiotics entered the global market. The majority of antibiotics released in this time period originated from Japanese or US companies and were launched in Japan or the US. Of the 25 antibiotics, 18 treat community-acquired respiratory infections, 14 treat skin infections, and 12 treat urinary infections. Half treat infections caused by resistant bacteria, but none targeted Gram-negative bacteria, which cause most untreatable infections.

The development, manufacture and sale of pharmaceutical drugs in the United States is a complex landscape of intellectual property and federal regulation. The status quo of the US pharmaceutical market may soon be turned on its head. That's due in part to a growing community of do-it-yourself 'biohackers' who are disrupting business-as-usual for pharmaceutical discovery, development and distribution.

New socioeconomic research from Michigan State University found a market disruptor has turned the 'invisible hand' theory on its head.

A team at NYU Tandon School of Engineering has found a way to prove the provenance of 3-D printed parts by embedding QR (Quick Response) codes in an innovative way for unique device identification. In the latest issue of Advanced Engineering Materials, the researchers describe converting QR codes into 3-D features so that that they neither compromise the part's integrity nor announce themselves to counterfeiters who have the means to reverse engineer the part.

Four years after their publication by the Office of the National Coordinator for Health Information Technology (ONC), voluntary guidelines designed to increase the safety of e-health records have yet to be implemented fully, according to a survey led by a researcher at The University of Texas Health Science Center at Houston (UTHealth). Findings appeared recently in the Journal of the American Medical Informatics Association.

A new analysis examines how changes in innovation within firms and a shortage of human capital in the United States in the fields of software and IT have driven US multinational companies to establish and expand new innovation hubs abroad.